Can-Fite BioPharma Ltd. Postemployment Benefit Expense Defined Benefit Plans
Can-Fite BioPharma Ltd. (CANF) reported Postemployment Benefit Expense Defined Benefit Plans of $8.00 thousand for the 12-month period ending 2019-12-31, per its 20-F filed 2020-03-27.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans · last filed 2020-03-27
| Period end | Postemployment Benefit Expense Defined Benefit Plans 12 month |
|---|---|
| 2019-12-31 | $8.00K 20-F · filed 2020-03-27 |
| 2016-12-31 | $12.00K 20-F · filed 2019-03-29 |